Search
for
Sort by
Research 151–180 of 477
- Steroid Hormones of Reproduction and Sexual Development
- Postmenopausal Alopecia (Hair Loss)
- Alopecia: managing the basics
- Medical Management Options for Hair Loss
- Clinical characterization of men with long QT syndrome and torsades de pointes associated with hypogonadism: A review and pharmacovigilance study
- Cardiodermatology: the heart of the connection between the skin and cardiovascular disease
- Epicardial Fat Thickness in Children with Classic Congenital Adrenal Hyperplasia
- Transgender and Migraine
- Acne
- The urine as a diagnostic key for a homozygous EGFR mutation
- Nonclassic congenital adrenal hyperplasia and the heterozygote carrier
- Complications of liver transplantation: A perioperative perspective
- ANIFROLUMAB IN THE MANAGEMENT OF LUPUS HEADACHES: A CASE REPORT
- ANDROGENETIC ALOPECIA: A REVIEW OF CURRENT THERAPEUTIC OPTIONS
- ASSOCIATION OF SYSTEMIC LUPUS ERYTHEMATOSUS AND CHRONIC GRANULOMATOUS DISEASE IN ADULTS: REPORT OF 2 CASES
- MIXED CONNECTIVE TISSUE DISEASE EVOLVING FROM THE SEQUENTIAL OVERLAP OF SYSTEMIC LUPUS ERYTHEMATOSUS, SJÖGREN’S SYNDROME, RHEUMATOID ARTHRITIS AND DERMATOMYOSITIS: A FOLLOW-UP
- Epicardial fat thickness in children with classic congenital adrenal hyperplasia
- Self-medication by Jockeys
- Harmless Herbs? A Review of the Recent Literature
- Treatment of invasive aspergillosis with itraconazole
- The Rotterdam Study: 2016 objectives and design update
- Deletion of Deoxyribonucleic Acid Binding Domain of the Vitamin D Receptor Abrogates Genomic and Nongenomic Functions of Vitamin D
- Severe cutaneous adverse reactions to drugs
- The pharmacology of methotrexate
- A Phase I Study of Topical Tempol for the Prevention of Alopecia Induced by Whole Brain Radiotherapy
- Recognition and management of <i>Staphylococcus aureus</i> toxin‐mediated disease
- Psoriasis of the Scalp
- Extraskeletal actions of vitamin D
- Protection Against Chemotherapy-Induced Alopecia
- Mechanisms of Disease: selective inhibition of 11β-hydroxysteroid dehydrogenase type 1 as a novel treatment for the metabolic syndrome